Normoxemic Extracorporeal Membrane Oxygenation Reduces Infarct Size and Preserves Mitochondrial Integrity in Preclinical Models of Acute Myocardial Infarction
Journal of Cardiovascular Translational Research · 2025
DOI: 10.1007/s12265-025-10654-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Translational Research, 2025. Verfasst von Shreyas Bhave und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Molecular Cardiology Research Institute, Tufts Medical Center, 800 Washington Street, Box # 80, Boston, MA, 02111, USA. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Myocardial Infarction, Mitochondria, Heart, Myocardial Reperfusion Injury. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association, NHLBI NIH HHS, American Heart Association-American Stroke Association.
Abstract (Originalsprache)
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) provides cardiopulmonary support during the critical care. Despite its exponential use over last few decades, clinical studies suggest that it does not improve infarct size and mortality in patients suffering from cardiogenic shock after the acute myocardial infarction (AMI). The effect of hyperoxygenated blood under high pressure on the poor outcomes associated with VA-ECMO have not been tested. In this study we tested the hypothesis whether normoxemic oxygenation of blood during provides protection against VA-ECMO associated cardiac damage using a swine model of AMI. Our results indicate that normoxemic VA-ECMO (PaO2 200 mmHg) in ischemia-reperfusion injury. In absence of conclusive clinical trials testing the effect of VA-ECMO blood oxygenation on the patients' outcomes, our findings provide new mechanistic insight into the myocardial effects of VA-ECMO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Molecular Cardiology Research Institute, Tufts Medical Center, 800 Washington Street, Box # 80, Boston, MA, 02111, USA.
- The Molecular Cardiology Research Institute, Tufts Medical Center, 800 Washington Street, Box # 80, Boston, MA, 02111, USA. Nkapur@tuftsmedicalcenter.org.
ORCID-Profile: Navin K Kapur
Förderung
- American Heart Association
- NHLBI NIH HHS
- American Heart Association-American Stroke Association
- National Heart, Lung, and Blood Institute
Zitieren
APA
Bhave, S., Swain, L., Reyelt, L., Qiao, X., Aryaputra, T., Everett, K., John, K., Berry, I., Stolyaranov, A., Mahmoudi, E., Chin, M., & Kapur, N. K. (2025). Normoxemic Extracorporeal Membrane Oxygenation Reduces Infarct Size and Preserves Mitochondrial Integrity in Preclinical Models of Acute Myocardial Infarction. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-025-10654-7
Vancouver
Bhave S, Swain L, Reyelt L, Qiao X, Aryaputra T, Everett K, et al. Normoxemic Extracorporeal Membrane Oxygenation Reduces Infarct Size and Preserves Mitochondrial Integrity in Preclinical Models of Acute Myocardial Infarction. Journal of Cardiovascular Translational Research. 2025. doi:10.1007/s12265-025-10654-7
BibTeX
@article{Bhave2025,
author = {Bhave, Shreyas and Swain, Lija and Reyelt, Lara and Qiao, Xiaoying and Aryaputra, Tejasvi and Everett, Kay and John, Kevin and Berry, Isabella and Stolyaranov, Arik and Mahmoudi, Elena and Chin, Michael and Kapur, Navin K},
title = {Normoxemic Extracorporeal Membrane Oxygenation Reduces Infarct Size and Preserves Mitochondrial Integrity in Preclinical Models of Acute Myocardial Infarction},
journal = {Journal of Cardiovascular Translational Research},
year = {2025},
doi = {10.1007/s12265-025-10654-7}
}
EUVIMED